Showing 1 - 3 results of 3 for search 'Nicole Niesler', query time: 0.03s Refine Results
  1. 1
    Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478

    Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins<... by Hossein Panjideh, Nicole Niesler, Alexander Weng, Hendrik Fuchs

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861

    Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861 by Hossein Panjideh, Nicole Niesler, Alexander Weng, Hendrik Fuchs

    Published 2022-07-01
    Get full text
    Article
  3. 3
    A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861

    A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861 by Finn J. Schulze, Mazdak Asadian-Birjand, Michael Pradela, Nicole Niesler, Gregor Nagel, Hendrik Fuchs

    Published 2024-04-01
    Get full text
    Article

Search Tools: